Safety of direct oral anticoagulants in real–world clinical practice: translating the trials to everyday clinical management-Reference-Cited by-同舟云学术

Safety of direct oral anticoagulants in real–world clinical practice: translating the trials to everyday clinical management

Published:2019-02-18 Issue:3 Volume:18 Page:187-209
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Fawzy Ameenathul M.¹,Yang Wang-Yang¹²,Lip Gregory YH.³

Affiliation:

1. Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, UK

2. Department of Cardiology, Beijing AnZhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China

3. Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK

Funder

paper was not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1578344

Reference117 articles.

1. Novel oral anticoagulants and the 73rd anniversary of historical warfarin

2. Trends in Prescription of Novel Oral Anticoagulants (NOACs) and Warfarin in Australia 2010-2015

3. Trends in the prescription of novel oral anticoagulants in UK primary care

4. National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011

5. Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apixaban, edoxaban and rivaroxaban but not dabigatran are associated with higher mortality compared to vitamin‐K antagonists: A retrospective German claims data analysis;Journal of Internal Medicine;2024-09-02

2. Edoxaban treatment in a post-infarction experimental model;European Journal of Pharmacology;2024-01

3. Changes of recommended anticoagulation therapy in patients with atrial fibrillation and high thrombotic risk: long-term follow-up data from two hospital centers;Expert Review of Cardiovascular Therapy;2021-08-13

4. Efficacy and safety of non-vitamin K antagonist oral anticoagulants for venous thromboembolism: a meta-analysis;JRSM Open;2021-06

5. The pleiotropic effects of antithrombotic drugs in the metabolic–cardiovascular–neurodegenerative disease continuum: impact beyond reduced clotting;Clinical Science;2021-04